Document:

<PAGE>
                                                                   Exhibit 10.17

                                  AGREEMENT FOR

                            ASSIGNMENT OF TRADEMARKS

THIS AGREEMENT is dated December _____, 2004 with effect as of Effective Date
between:

______________________, a ______________________ corporation ("Assignor")

AND

______________________, a ______________________ ("Assignee")

A.       Assignor is the owner of the trademarks described on Exhibit A,
         attached hereto (the "Trademarks");

B.       Assignee is expected to become a Subsidiary of Novelis Inc. pursuant to
         the terms of a Separation Agreement between Alcan Inc. and Novelis Inc.
         ("Separation Agreement").

C.       Assignor wishes to assign the Trademarks to Assignee and Assignee
         wishes to accept such assignment.

THEREFORE, the parties agree as follows:

1.       Effective Date

         This Agreement shall be effective as of the date on which the Assignee
         becomes a subsidiary of Novelis Inc.

2.       Assignment

         In consideration for the obligations undertaken by Assignee under the
         Agreements to which it is a party and which are referenced in the
         Separation Agreement, Assignor hereby assigns and transfers to Assignee
         all of Assignor's right, title and interest in and to the Trademarks
         and all goodwill associated with the Trademarks.

3.       Assignments

         Assignor shall execute and deliver to Assignee assignments in the form
         reasonably prescribed by Assignee or applicable law to effect
         assignments of the registrations of the Trademarks. Each of the parties
         shall execute such further documents and perform such further acts as
         may be reasonably required or desirable to carry out such assignments.

<PAGE>
4.       Miscellaneous

         a.       This Agreement shall be governed by and construed in
                  accordance with the laws of the Province of Quebec and the
                  laws of Canada applicable therein. Each party irrevocably
                  submits to the exclusive jurisdiction of the Courts of
                  competent jurisdiction in such province for all purposes in
                  connection with this Agreement.

         b.       INTENDING TO BE LEGALLY BOUND, the parties hereto have duly
                  executed this Agreement as of the day and year first above
                  written.

ASSIGNOR:                                 ASSIGNEE:

By: _____________________________         By: ________________________________

Title: __________________________         Title: _____________________________<PAGE>

                                                                   Exhibit 10.19

                         INTELLECTUAL PROPERTY AGREEMENT

                                     BETWEEN

                           ALCAN INTERNATIONAL LIMITED

                                       AND

                                  NOVELIS INC.

1 January 2005

<PAGE>

                                TABLE OF CONTENTS

1.0 PREAMBLE...................................................................1

2.0 DEFINITIONS................................................................1

3.0 TRANSFER OF TECHNOLOGY.....................................................7

4.0 LICENSE RIGHTS GRANTED....................................................10

5.0 EXCLUDED TECHNOLOGY.......................................................12

6.0 TERMINATION OF PARTICIPATION IN JTA.......................................14

7.0 PROTECTION OF INFORMATION.................................................15

8.0 TERM AND TERMINATION......................................................16

9.0 SURVIVAL OF OBLIGATIONS...................................................18

10.0 REPRESENTATIONS..........................................................18

11.0 DISCLAIMER...............................................................18

12.0 TRADEMARK, TRADE NAME AND LOGO...........................................19

13.0 NON-WAIVER...............................................................20

14.0 NO PARTNERSHIP, JOINT VENTURE............................................20

15.0 FURTHER ASSURANCES, CONSENTS, ETC........................................20

16.0 NOTICES..................................................................20

17.0 ASSIGNMENT...............................................................21

18.0 INDEMNIFICATION..........................................................22

19.0 ENTIRE AGREEMENT, AMENDMENTS.............................................24

20.0 DISPUTE RESOLUTION  .....................................................24

21.0 MISCELLANEOUS............................................................24

22.0 GOVERNING LAW............................................................25

<PAGE>

                         INTELLECTUAL PROPERTY AGREEMENT

This Intellectual Property Agreement is entered into with effect as of the
Effective Date.

BETWEEN:       Alcan International Limited, a Canadian corporation having its
               head office at 1188 Sherbrooke Street West, Montreal, Quebec,
               Canada (hereinafter referred to as "Alcanint")

AND:           Novelis Inc., a Canadian corporation having its registered office
               at 1188 Sherbrooke Street West, Montreal, Quebec, Canada
               (hereinafter referred to as "NOVELIS") acting as principal and
               as agent for other members of Novelis Group, as herein provided.

WHEREAS, Alcanint is a  wholly-owned subsidiary of Alcan; and

WHEREAS, Alcan Inc. and Novelis have entered into the Separation Agreement with
effect as of the Effective Date, which provides, among other things, for the
transfer of certain assets from Alcan to Novelis and the assumption by Novelis
of certain liabilities in connection with the distribution of common shares of
Novelis to Alcan shareholders and the execution and delivery of certain other
agreements, including this Agreement; and

WHEREAS Alcanint owns and manages certain technology on behalf of and for the
benefit of Alcan and its Affiliates and desires to transfer or license to
Novelis certain rights in technology owned by it;

WHEREAS a further purpose of this Agreement is to achieve compliance with
regulatory requirements in respect of the separation of certain aluminum rolling
assets from Alcan in a manner which allows them to continue to be viable;

NOW THEREFORE, in consideration of the foregoing and the mutual agreements set
forth below, and other good and valuable consideration, the receipt and adequacy
of which is hereby acknowledged, the parties hereto agree as follows:

1.0   PREAMBLE

      The preamble hereto shall be considered an integral part of this
      Agreement.

2.0   DEFINITIONS

      2.1   "AEROSPACE INDUSTRY" shall mean the production of aircraft,
            spacecraft, satellites and similar craft for manned or unmanned
            flight;

      2.2   "AFFILIATE" shall mean, with respect to any corporation, association
            or other business entity, any other entity directly or indirectly
            controlling, controlled by or under common control with such
            specified corporation, association or entity.

                                       1
<PAGE>

            For purposes of this definition, "control" (including, with
            correlative meanings, the terms "controlling," "controlled by" and
            "under common control with"), means the possession, directly or
            indirectly, of the power to direct or cause the direction of
            management or policies, whether through the ownership of voting
            securities, by agreement or otherwise; provided, however, that
            beneficial ownership of 10% or more of the securities or other
            interest entitled to vote generally in the election of directors
            shall be deemed to be control;

      2.3   "AGREEMENT" shall mean this Intellectual Property Agreement and all
            other documents that are made a part hereof;

      2.4   "ALCAN" shall mean Alcan Inc., a Canadian corporation;

      2.5   "ALCAN GROUP COMPANY" shall mean Alcan or any entity of which a
            majority of the total voting power of capital stock or other
            interests entitled (without regard to the occurrence of any
            contingency) to vote in the election of directors, managers or
            trustees thereof is at the time owned or controlled, directly or
            indirectly, by Alcan;

            2.5A  "ARRANGEMENT" shall have the meaning ascribed to such term in
                  the Separation Agreement;

      2.6   "AUTOMOTIVE SHEET" shall mean aluminum Sheet products destined or
            intended for use in or principally related to the production of
            inner and outer body panels (including closures, skin, hoods,
            deckslids and fenders) and Sheet-based body-in-white structures for
            road vehicles;

      2.7   "AUTOMOTIVE SHEET PATENTS" shall mean the patents and patent
            applications in respect of Automotive Sheet as listed in Appendix
            ASP;

      2.8   "COCAST TECHNOLOGY" shall mean the Technology originally developed
            by Wagstaff Inc. and further developed by Alcan Group Companies,
            primarily at the Solatens Facility, related to the casting of
            composite ingots with distinct regions having different alloy
            compositions as generally described in the patents and patent
            applications listed in Appendix CCT;

      2.9   "DESIGNATED PATENTS" shall mean patents and patent applications
            owned by Alcanint and listed in Appendix DP;

      2.10  "EFFECTIVE DATE" shall mean the Effective Date as defined in the
            Separation Agreement;

      2.11  "EXCLUDED TECHNOLOGY" shall mean the Technology described in Section
            5.1;

                                       2
<PAGE>

      2.12  "FLEXCAST TECHNOLOGY" shall mean the Technology specific to
            continuous casting of a thin strip between two chilled metallic
            belts as generally described in the patents and patent applications
            listed in Appendix FCT;

      2.13  "FLEXSTREME TECHNOLOGY" shall mean the Technology and equipment
            designs originally developed by Wagstaff Inc. and further developed
            by Alcan Group Companies, primarily at the Solatens Facility,
            related to the horizontal direct chill casting of small diameter
            ingots suitable for use as forging stock as generally described in
            the patents and patent applications listed in Appendix FST;

      2.14  "INSITU HOMOGENIZATION TECHNOLOGY" shall mean ***

      2.15  "JOINT TECHNOLOGY AGREEMENTS" or "JTAS" shall mean the Agreements
            between Alcanint and various other Alcan Group Companies for joint
            research and technical assistance in the field of aluminum and other
            materials fabricating and/or aluminum reduction and/or the
            production of raw materials for the production of aluminum and/or
            manufacturing packaging using aluminum foil and other materials;

      2.16  "LICENSED PATENTS" shall mean the patents and patent applications
            listed in Appendix LP;

      2.17  "LICENSED EQUIPMENT PATENTS" shall mean the patents and patent
            applications listed in Appendix LEP;

      2.18  "LICENSED TECHNOLOGY" shall mean any and all, copyrights, trade
            secrets, information, data, inventions, designs and similar rights
            that have been used or developed, or are being used or developed for
            use by Novelis or any Novelis Subsidiaries on or immediately before
            the Effective Date for or in connection with the use and
            exploitation of any one of the facilities that form part of Novelis
            as of the Effective Date that are related to the following:

            o     Sheet ingot casting and metallurgy and associated melting,
                  metal cleaning, molten metal delivery, quality measurement and
                  environmental technologies;

            o     laminated products as pursued as of the Effective Date at the
                  Ohle, Ludensheid, Berlin, Bridgnorth or Etobicoke foil
                  operations of Alcan;

      *** Certain information on this page has been omitted and filed separately
          with the Securities and Exchange Commission. Confidential treatment
          has been requested with respect to the omitted portions.

                                       3
<PAGE>

            o     Technology specific to the production of rolled Plate with a
                  thickness of less than 12mm to the extent that such technology
                  was in use immediately prior to the Effective Date at
                  manufacturing facilities that will form a part of Novelis as
                  of the Effective Date;

            o     the Ouro Preto/Aratu/Petrocoque Technology;

            Licensed Technology shall also include all Technology related to
            management systems and business processes including environment
            health and safety, value based management, continuous improvement,
            production scheduling and management and individual performance and
            career management and all business forms, contract forms, and other
            written and electronic business materials used by Novelis or a
            Novelis Subsidiary prior to the Effective Date subject in each case
            to Novelis obtaining at its sole cost any necessary consents,
            provided that all such Technology and materials have been modified
            as necessary to delete any reference to brand names, trademarks,
            service marks being retained by Alcan Group Companies.

      2.19  "NETCAST TECHNOLOGY" shall mean the Technology originally developed
            by Wagstaff Inc. and further developed by Alcan Group Companies,
            primarily at the Solatens Facility, related to the direct chill
            casting of complex shapes certain aspects of which are described in
            the patents and patent applications listed in Appendix NCT;

            2.19A "NOVELIS GROUP" means Novelis and the Novelis Subsidiaires.

      2.20  "NOVELIS SUBSIDIARY" shall mean, as of and from the Effective Date,
            (i) Petrocoque S.A. - Industria E Comercio, Aluminium Norf GmbH and
            Logan Aluminum Inc, in each case for so long as Novelis retains at
            least its current ownership stake in such entity and (ii) any other
            entity of which a majority of the total voting power of capital
            stock or other interests entitled (without the occurrence of any
            contingency) to vote in the election of directors, managers or
            trustees thereof is at the time owned or controlled, directly or
            indirectly by Novelis;

      2.21  "OURO PRETO/ARATU/PETROCOQUE TECHNOLOGY" shall mean the Technology
            employed in the operations of any one or more of the facilities
            known as Ouro Preto, Aratu and Petrocoque as of the Effective Date.
            Ouro Preto is a bauxite mine, alumina refinery and aluminum smelter,
            Aratu is an aluminum smelter with an associated electricity
            generating facility; and Petrocoque is a facility that produces
            calcined petroleum coke;

            2.21A "PECHINEY" means Pechiney, a wholly-owned subsidiary of Alcan,
                  together with all entities that were subsidiaries of Pechiney
                  when Pechiney became a subsidiary of Alcan, in December 2003.

                                       4
<PAGE>

      2.22  "PAE TWIN ROLL CASTING TECHNOLOGY" shall mean Technology specific to
            the continuous casting of a relatively thin metal strip between two
            chilled rolls which is marketed by Pechiney Aluminium Engineering
            certain aspects of which are described in the patents and patent
            applications listed in Appendix TRCT;

      2.23  "PAE METAL TREATMENT TECHNOLOGY" shall mean Technology specific to
            the melting, holding and casting of aluminum, treatments of molten
            aluminum to remove hydrogen, solid and liquid inclusions and alkali
            metal and related equipment namely IRMA, JetCleaner, Alpur, PDBF,
            CCF and Autopak which is marketed by Pechiney Aluminium Engineering
            as of the Effective Date, certain aspects of which are described in
            the patents and patent applications listed in Appendix MTT;

      2.24  "PLATE" shall mean rolled and/or cast aluminum product with a
            thickness of greater than 6.5mm that is not intended for further
            rolling to a thickness of 6.5mm or less (reroll);

      2.25  "ROLLED PRODUCTS" means rolled aluminum products in the form of
            Foil, Sheet and rolled Plate of a thickness of less than 12 mm;

      2.26  "SECONDARY INTELLECTUAL PROPERTY AGREEMENT" shall mean that other
            Intellectual Property Agreement of even date herewith between
            Novelis as party of the first part and Alcanint as party of the
            second part;

      2.27  "SEPARATION AGREEMENT" shall mean the Separation Agreement herewith
            between Alcan and Novelis, as described in the Preamble to this
            Agreement;

      2.28  "SHEET" and "FOIL" shall have the same meaning as is commonly
            ascribed to those expressions in the aluminum industry in reference
            to rolled aluminum provided that it is of a thickness of 6.5mm or
            less;

      2.29  "SOLATENS FACILITY" shall mean the facility in Spokane, Washington
            known as Solatens;

      2.30  "TECHNOLOGY" shall mean any and all patents, patent applications,
            copyrights, trade secrets, information, data, inventions, designs,
            manufacturing processes, know-how, technical information,
            specifications, creative works and similar rights either conceived
            or first reduced to practice on or before the Effective Date that
            are owned, licensable or otherwise under the control and direction
            of Alcanint or any other Alcan Group Company before the Effective
            Date, including Novelis Subsidiaries;

      2.31  "TRANSFERRED TECHNOLOGY" shall mean the Technology described in
            Section 3.1; and

                                       5
<PAGE>

      2.32  "UNRESTRICTED LICENSED TECHNOLOGY" shall mean any and all,
            copyrights, trade secrets, information, data, inventions, designs
            and similar rights that have been used or developed, or are being
            used or developed for use in connection with research, development,
            production, marketing or sale of Rolled Products by Novelis or any
            Novelis Subsidiary on or immediately before the Effective Date or in
            connection with the use and exploitation of any of the facilities
            owned or operated by Novelis or a Novelis Subsidiary as of the
            Effective Date that are freely licensable by Alcanint or any Alcan
            Group Company and related to the following:

            o     Recycling aluminum, scalping, homogenization and preheating
                  technology, hot rolling, cold rolling, foil rolling, coiling,
                  cooling and lubrication, continuous and batch heat treatment,
                  quenching, mechanical finishing, slitting, cutting to length,
                  laser blanking and all associated technologies (e.g. profile,
                  gauge and shape measurement and control and pollution
                  reduction and control);

            o     Mechanical finishing, surface texturing, chemical
                  pre-treatment, painting, lacquering and curing technologies
                  for Sheet and Foil;

            o     Metallurgy related to the properties and microstructural
                  evolution through continuous casting, hot rolling, coiling,
                  cooling, cold rolling, foil rolling, heat-treatment,
                  quenching, mechanical finishing, and downstream finishing and
                  fabrication processes for sheet, foil and sheet ingot applied
                  internally or by customers for Sheet and Foil (e.g. forming,
                  rolling, painting and lacquering, curing and etching of Sheet
                  and Foil);

            o     Manufacture of rigid and semi-rigid aluminum foil containers
                  and closures;

            o     Metal property and alloy composition specifications related to
                  Rolled Products;

            o     In-service sheet and foil product performance in terms of
                  mechanical property changes, corrosion (bare and surface
                  treated Sheet) in final applications;

            o     All process simulation models, scheduling and productivity
                  models and historic information to the extent recorded and
                  relevant to the Licensed Technology, Unrestricted Licensed
                  Technology or Transferred Technology;

            o     Enabling Technologies and know-how related to processes and
                  application of aluminum Rolled Products materials used by
                  customers (e.g. AVT automotive body-in-white assembly process,

                                       6
<PAGE>

                  spot welding, adhesive bonding, riveting technologies, etching
                  and finishing, structural simulation models pertinent to
                  applications); and

            o     Technology for the production of Foil to the extent it is
                  being used or has been used under existing or past practices
                  at the former Pechiney Annecy, Rugles, Dudelange and Flemalle
                  sites for the sole purpose of painting Sheet or producing
                  circles from Sheet or producing Foil.

            o     Technology specific to making and using the inventions claimed
                  in the Designated Patents and the Automotive Sheet Patents;

            o     All other Technology, other than Excluded Technology, that is
                  in use or held for use as of the Effective Date in connection
                  with the research, development, production, marketing or sale
                  of Rolled Products at the facilities of Novelis and the
                  Novelis Subsidiaries as of the Effective Date subject to
                  Alcanint's right, upon reasonable request, to be informed as
                  to the identity, scope and use of such other Technology;

      2.33  In the event of any ambiguity as to the inclusion of a particular
            Technology within Excluded Technology, Licensed Technology,
            Transferred Technology, or Unrestricted Licensed Technology, such
            Technology still be allocated in the following order of preference:
            (1) Transferred Technology; (2) Excluded Technology; (3) Licensed
            Technology; and (4) Unrestricted Licensed Technology.

3.0   TRANSFER OF TECHNOLOGY

      3.1   Alcanint hereby grants, conveys, transfers and assigns and agrees to
            deliver (and agrees to cause any appropriate Alcan Group Company to
            grant, convey, transfer, assign and agree to deliver) to Novelis, in
            its capacity as principal for the sole purpose of acquiring legal
            title therein, and in its capacity as agent for the relevant members
            of Novelis Group for the purpose of acquiring all beneficial
            ownership therein and for all other purposes, all right, title and
            interest, of whatever nature or kind throughout the world of
            Alcanint or any Alcan Group Company in and to the following:

            3.1.1 the Designated Patents;

            3.1.2 the Automotive Sheet Patents and related Technology which is
                  only useful in the production of Automotive Sheet and which
                  originated: (i) without use of or reference to Technology
                  owned or developed by Pechiney, and (ii) within a business
                  unit or manufacturing facility that will be owned by Novelis
                  Group as of the Effective Date;

                                       7
<PAGE>

            3.1.3 Technology that is only useful in the production of beverage
                  can body Sheet, beverage can end Sheet and tab stock (for
                  beverage cans) which originated: (i) without use of or
                  reference to Technology owned or developed by Pechiney, and
                  (ii) within any business unit or manufacturing facility that
                  will form part of Novelis as of the Effective Date;

            3.1.4 NetCast Technology, CoCast Technology, FlexStreme Technology
                  and Insitu Homogenisation Technology;

            3.1.5 PAE Twin Roll Casting Technology and FlexCast Technology, in
                  both cases subject to Schedule FT;

            3.1.6 PAE Metal Treatment Technology;

            3.1.7 the right to grant licenses and rights under and with respect
                  to any of the foregoing and to sue for any infringement
                  occurring before or after the Effective Date as well as all
                  statutory, contractual and other claims, demands and causes of
                  action for royalties, fees or other income from, or
                  infringement, misappropriation or violation of, any of the
                  foregoing, and all of the proceeds from the foregoing that are
                  accrued and unpaid as of, and/or accruing after, the Effective
                  Date;

            3.1.8 all causes of action and rights of recovery against third
                  parties for past infringement in and to the Transferred
                  Technology, and for past misappropriation by third parties of
                  trade secrets in and to the Transferred Technology; and

            3.1.9 the right to apply for and obtain statutory rights and
                  registrations with respect to any of the foregoing Technology.

      3.2   The foregoing transfer and assignment shall be subject to the
            licenses granted to Alcanint and other Alcan Group Companies
            pursuant to the Secondary Intellectual Property Agreement.

      3.3   If and to the extent that, as a matter of law in any jurisdiction,
            ownership, title, or any rights of interest in or to any of the
            Transferred Technology cannot be assigned as provided in Section
            3.1, (i) Alcanint agrees subject to the other terms and conditions
            of this Agreement to assign and transfer, and hereby assigns and
            transfers to Novelis (as agent for the relevant member of Novelis
            Group) all rights (including, without limitation, all economic and
            commercialization rights) that can be assigned pursuant to Section
            3.1 to the fullest extent permissible; and (ii) Alcanint agrees
            subject to the other terms and conditions of this Agreement to
            grant, and hereby grants, Novelis (as agent for the relevant member
            of Novelis Group) an unlimited, exclusive, irrevocable, worldwide,
            perpetual, royalty-free license, to use, exploit and commercialize
            in any manner now known or in the future discovered and for

                                       8
<PAGE>

            whatever purpose, any rights to Transferred Technology that cannot
            be assigned as contemplated by Section 3.1.

      3.4   Alcanint further covenants that it will, without demanding any
            further consideration therefor, at the request and expense of
            Novelis (except for the value of the time of Alcanint employees), do
            (and cause Alcan Group Companies to do) all lawful and just acts
            that may be or become necessary for evidencing, maintaining,
            recording and perfecting Novelis' rights to such Transferred
            Technology consistent with Alcan's general business practice as of
            the Effective Date, including but not limited to, execution and
            acknowledgement of (and causing Alcan Group Companies to execute and
            acknowledge) assignments and other instruments in a form reasonably
            required by Novelis for each relevant jurisdiction.

      3.5   Alcanint and each other Alcan Group Company shall retain any
            Technology not transferred to Novelis by virtue of the foregoing.
            Novelis warrants to Alcanint that neither it nor any Novelis
            Subsidiary owns any Technology (other than the Transferred
            Technology and only to the extent conveyed hereunder) as of the
            Effective Date and further acknowledges that any other Technology
            that it or any Novelis Subsidiary may be deemed to have owned prior
            to the Effective Date was intended to be owned by Alcanint and shall
            be deemed to have been held by Novelis or such Novelis Subsidiary
            for the benefit of Alcanint. This provision shall not apply to that
            Technology described in the final paragraph of Section 2.18.

      3.6   Each of Alcanint and Novelis shall deliver to the other all
            documents and instruments necessary or appropriate to be duly
            executed where appropriate by the applicable party(ies) and
            notarized where indicated in the exhibits to this Agreement.

      3.7   Novelis acknowledges and agrees that the foregoing assignment is
            subject to any and all licenses or other rights that may have been
            granted by Alcanint or any other Alcan Group Company with respect to
            the Transferred Technology prior to the Effective Date.

      3.8   The determination regarding which Novelis Group company (sometimes
            referenced in this Agreement as the "relevant member of Novelis
            Group") shall be entitled to beneficial ownership of Transferred
            Technology or to a license of Licensed Patents, Unrestricted
            Licensed Technology or Licensed Technology shall be made having
            regard to the following factors:

            3.8.1 whether the relevant member of Novelis Group was a party to
                  any JTA while such entity was an Alcan Group Company;

            3.8.2 whether the relevant member of Novelis Group reasonably
                  requires the relevant beneficial ownership or license in
                  connection with the ownership

                                       9
<PAGE>

                  or operation of one or more of its businesses on and after the
                  Effective Date, based on the use of Technology in connection
                  with such business prior to the Effective Date; and

            3.8.3 such other factors as may reasonably be taken into account by
                  Novelis and as are consistent with the provisions of this
                  Agreement.

      3.9   Novelis covenants that it will enter into such agreements with the
            relevant members of Novelis Group as may be necessary or desirable
            for the orderly management of the Technology mentioned in section
            3.8.

4.0   LICENSE RIGHTS GRANTED

            4.1.1 Alcanint hereby grants to Novelis and Novelis hereby accepts,
                  as agent for the relevant members of Novelis Group and subject
                  to the terms and conditions of this Agreement a royalty free
                  license to use and commercialize the Licensed Patents,
                  Unrestricted Licensed Technology and Licensed Technology to
                  operate, maintain, repair, reconstruct, rebuild and expand any
                  present or future facilities of Novelis Group and to use and
                  sell the products produced using the Licensed Patents,
                  Unrestricted Licensed Technology and/or the Licensed
                  Technology pursuant thereto world wide; provided that the
                  royalty free license in respect of the Ouro
                  Preto/Aratu/Petrocoque Technology shall be limited such that
                  it may be used only at the same geographic sites.

            4.1.2 Pursuant to the license granted under Section 4.1.1, Novelis
                  shall be permitted to sublicense any Unrestricted Licensed
                  Technology except to the extent the use of such Unrestricted
                  Licensed Technology is covered by patents held by Alcanint or
                  any other Alcan Group Company.

            4.1.3 Novelis may grant sublicenses under the Licensed Patents and
                  the Licensed Technology (i) to third parties (such as
                  customers and vendors) to the extent necessary or appropriate
                  to give commercial effect to the rights sought to be
                  transferred, assigned or licensed hereunder and (ii) to
                  Novelis Subsidiaries provided that any such sublicense may be
                  made effective retroactively but not prior to the
                  sublicensee's becoming a Novelis Subsidiary and any such
                  sublicense shall terminate immediately upon such sublicensee
                  no longer being a Novelis Subsidiary, except in a transaction
                  that meets the conditions of Section 17.2.

      4.2   All licenses granted to Novelis under this Agreement are personal,
            indivisible, royalty-free, non-exclusive, and non-transferable
            except as otherwise specifically provided herein, and shall be
            subject to all terms and conditions herein set forth and apply only
            to the extent herein specified and defined. The

                                       10
<PAGE>

            non-exclusive licenses granted hereunder shall exist as long as this
            Agreement is effective in accordance with Article 8.0, provided,
            however that the non-exclusive licenses granted hereunder is subject
            to termination in accordance with Article 8.0.

            4.2.1 Alcanint hereby grants to Novelis (and agrees to cause any
                  appropriate Alcan Group Company to grant to Novelis) and
                  Novelis hereby accepts, as agent for the relevant members of
                  Novelis Group and subject to the terms and conditions to this
                  Agreement (i) a royalty-free right and license to operate,
                  maintain and repair equipment subject to the Licensed
                  Equipment Patents that was acquired prior to the Effective
                  Date and to use and sell the products produced therewith on a
                  world-wide basis and (ii) a conditional royalty-free right and
                  license to use the Licensed Equipment Patents to build,
                  operate, maintain, repair, reconstruct, rebuild and expand any
                  present or future facilities of Licensee and to use and sell
                  the products produced therewith on a world-wide basis.

            4.2.2 To the extent that (i) Alcanint continues the commercial sale
                  of equipment for implementing any Licensed Equipment Patent
                  either directly or through a licensee and (ii) Alcanint or its
                  licensee offers such equipment to Novelis for sale on terms
                  and conditions (including royalties) at least as favourable to
                  Novelis as the best of those offered to any third party during
                  the previous 24 months or, if no such equipment has not been
                  offered within the previous 24 months at market rates (such
                  conditions (i) and (ii) being referred to herein as a
                  "COMMERCIAL LICENSE"), then Novelis shall operate under the
                  terms of such Commercial License rather than the licenses
                  granted in clause (ii) herein which shall be deemed suspended
                  until the occurrence of condition (i) or (ii) above. At any
                  time thereafter, Novelis shall be entitled to operate under
                  the license granted under clause (ii) or Section 4.2.1 as the
                  case may be, with no further action required by either
                  Alcanint or Novelis provided that Novelis shall provide
                  reasonably prompt notice to Alcanint that Novelis is operating
                  under the license set forth in paragraph 4.2 (ii). The
                  licenses provided for in clause (ii) of Section 4.2.1 shall
                  not apply to any equipment purchased by Novelis prior to the
                  date of such notice for implementing Licensed Equipment
                  Patents to the extent that equipment has been acquired with a
                  valid Commercial License. Such previously purchased equipment
                  shall continue to be operated under the terms and conditions
                  specified at the time such equipment was acquired by Novelis.

            Except as otherwise specifically provided in this Agreement, Novelis
            is not granted and does not have the right to assign, sub-license or
            otherwise dispose of the Licensed Patents or Licensed Technology or
            any part thereof.

      4.3   Except as otherwise specifically provided in this Agreement,
            Alcanint shall retain all right, title and interest in and to the
            Licensed Technology and

                                       11
<PAGE>

            Licensed Patents including the right (but not the obligation) to
            file for, prosecute and maintain any applications, registrations or
            recordation thereof and to bring any action to enforce or otherwise
            seek to abate any infringement thereof.

      4.4   Novelis shall have the right (to be exercised reasonably) from time
            to time to request additional information concerning the Transferred
            Technology, Licensed Technology, Unrestricted Licensed Technology
            and Licensed Patents. Alcanint shall, subject to the availability of
            appropriate personnel, supply the information so requested with the
            related cost and expense of doing so, if any, being for Novelis'
            account.

5.0   EXCLUDED TECHNOLOGY

      5.1   For the avoidance of doubt, all Technology that is not clearly
            identified as one of Licensed Patents, Licensed Equipment Patents,
            Licensed Technology, Unrestricted Licensed Technology or Transferred
            Technology shall not be transferred pursuant to Article 3.0 nor
            shall it be licensed pursuant to Article 4.0, all rights in such
            Technology shall be retained by Alcanint and such Technology shall
            be deemed "EXCLUDED TECHNOLOGY" and any license or right granted
            hereunder shall be specifically limited such that no right, license
            or permission to use Excluded Technology is granted. Without
            limitation and notwithstanding anything else contained herein,
            "Excluded Technology" specifically includes:

            o     all Technology owned or licensable or controlled by Pechiney
                  except for the following Technology to the extent such
                  Technology is otherwise agreed to be transferred or licensed
                  hereunder: (i) the PAE Twin Roll Casting Technology; (ii) the
                  PAE Metal Treatment Technology; and (iii) other Technology to
                  the extent that it is being used or has been used under the
                  existing or past practice at the former Pechiney Annecy,
                  Rugles, Dudelange and Flemalle sites for the sole purpose of
                  painting Sheet or the production of circles from Sheet or the
                  production of Foil;

            o     all Technology specific to the production of bright Sheet,
                  reflector Sheet and capacitor Foil to the extent that the
                  rights thereto originated with the 2000 acquisition by Alcan
                  of Alusuisse Group AG together with any subsequent
                  improvements thereto made at the Singen facility;

            o     all Technology related to the production and application of
                  metal - non-metal bonded composites (e.g. Alucobond),
                  structural composites, foamed plastics, balsa wood products,
                  honeycomb-cored composites, non-aluminum core materials and
                  roll bond Sheet and components made from roll bond except for
                  any such Technology related to the production and application
                  of laminates

                                       12
<PAGE>

                  typically used for roofs, walls, ceilings, automotive
                  applications and caravans (e.g., FF2, FF2 Plus, FALZONALI and
                  AluSilent) or anti-graffiti composite products (e.g.,
                  Aluclean) that are in use or held for use as of the Effective
                  Date in connection with the research, development, production,
                  marketing or sale such products at the facilities of Novelis
                  and the Novelis Subsidiaries;

            o     all Technology specific to the production and application of,
                  diecastings, forgings, except forging stock, non-Rolled
                  Products mass transport systems, non-Rolled Products
                  automotive components and assemblies (e.g. auto bumper beams,
                  crash management systems, side impact beams, cockpit carriers,
                  and certain BIW sub-assemblies, chassis parts and engine
                  cradles) except to the extent that any such Technologies are
                  in use or held for use as of the Effective Date in connection
                  with the research, development, production, marketing or sale
                  of Rolled Products at the facilities of Novelis and the
                  Novelis Subsidiaries;

            o     all Technology related to the mining of bauxite, the refining
                  and production of alumina and alumina based chemicals other
                  than the Ouro Preto/Aratu/Petrocoque Technology to the extent
                  licensed under Section 4.1;

            o     all Technology related to the smelting, the operation of
                  smelters, reduction and other processes and techniques
                  relating to the production of molten aluminum metal from
                  alumina or other ores, the generation and transmission of
                  electricity and related technologies other than the Ouro
                  Preto/Aratu/Petrocoque Technology to the extent licensed under
                  Section 4.1;

            o     all Technology other than Technology related only to Foil that
                  is specific to the manufacturing of any packaging related
                  products made from or incorporating rigid plastics, flexible
                  plastics, carton, steel, glass or paper but subject to the
                  rights under Section 4.2.2(i) and except for any such
                  Technology that was in use or in development for use in May
                  2004 in connection with, manufacturing activities conducted at
                  the Ohle, Ludensheid, Berlin, Bridgnorth and Etobicoke
                  facilities;

            o     all Technologies specific to the production of magnesium
                  chloride and magnesium metal.

      5.2   For the avoidance of doubt, the rights and licenses granted in
            Technology pursuant to Article 3.0 and licensed pursuant to Article
            4.0, do not grant such rights and licenses to use any of Licensed
            Patents, Licensed Technology, Unrestricted Licensed Technology

                                       13
<PAGE>

            or Transferred Technology in the following fields:

            o     Plate, except to the extent that they relate to rolled Plate
                  of a thickness of less than 12mm and except as otherwise
                  specifically permitted in Appendix PE;

            o     products destined or intended for use in the Aerospace
                  Industry;

            o     aluminum lithium alloys and Series 2000 and Series 7000
                  alloys;

            o     production and application of aluminum extruded products and
                  multi-material co-extrusions for all markets, including the
                  casting of extrusion billet except to the extent that they
                  relate to casting extrusion billet using FlexStream Technology
                  and except that Novelis may continue to use such co-extrusion
                  Technology that is being used in, has been used in or is being
                  developed for use in the manufacturing activities conducted by
                  Novelis at the Ludensheid facility to produce products for its
                  existing markets (e.g. cable wrap and pipes);

            o     production and application of continuous cast bar, rolled rod
                  and products made therefrom including rod, strip, wire and
                  cables; and

            o     smooth wall containers adapted for the application of heat
                  sealed lids and such lids, destined or intended for use in the
                  packaging of pet food and coating and/or laminating strip used
                  in their manufacture.

6.0   TERMINATION OF PARTICIPATION IN JTA

      6.1   As of the Effective Date and provided that the Arrangement becomes
            effective, Novelis and all Novelis Subsidiaries will cease to be
            Participants in the JTAs as that term is defined in the JTAs. In
            consideration of the rights and licenses granted herein and other
            good and valuable rights received pursuant to the Distribution and
            related Agreements, Novelis hereby grants and will cause each such
            Participant to grant to Alcanint all rights of such Participants in
            technology developed under the JTAs.

      6.2   Alcanint on behalf of the Participants in the JTAs hereby releases
            Novelis and the Novelis Subsidiaries from all obligations under the
            JTAs as of the Effective Date, provided that Novelis and the Novelis
            Subsidiaries shall remain responsible for performance of all of
            their respective obligations under the JTA, up to and including the
            Effective Date; and provided further that any default in the
            performance of these obligations shall be deemed a default
            hereunder.

                                       14
<PAGE>

7.0   PROTECTION OF INFORMATION

      7.1   Alcanint and Novelis hereby agree that the Licensed Technology made
            available to or produced or developed for the other party at any
            time and Excluded Technology that may be in the possession of
            Novelis (the "INFORMATION") is confidential information of Alcanint
            and shall not be disclosed to any third party except as may be
            expressly provided for herein and that Novelis shall have only such
            rights in the Information as are expressly provided herein.

      7.2   The obligations of confidentiality and non-disclosure shall not
            apply to Information to the extent that said Information:

            7.2.1 is in the public domain through no fault of Novelis, or
                  lawfully is or becomes public knowledge through no breach of
                  this Agreement;

            7.2.2 was received from any third party on a non-confidential basis
                  and did not originate from Alcanint or any Alcan Group
                  Company; or

            7.2.3 was disclosed by Novelis pursuant to legal process,
                  governmental request or regulatory requirement; provided,
                  however, that Novelis shall use all reasonable efforts to
                  provide notice to Alcanint in order to afford Alcanint a
                  reasonable opportunity to seek a protective order or an
                  injunction.

      7.3   Specific information shall not be deemed to be within the exceptions
            of Section 7.2 above merely because such specific information may be
            construed as being within broader, non-confidential information
            which is either in the public domain or the possession of the
            receiving party on the Effective Date, nor shall a combination of
            features which form confidential information be deemed to be
            non-confidential information merely because the individual features,
            without being combined, are non-confidential.

      7.4   Novelis shall not use the Information received hereunder for any
            purpose other than that specified in this Agreement without first
            obtaining written consent from Alcanint.

      7.5   Novelis may disclose the Information relating to Licensed Technology
            received hereunder to its officers, employees, contractors,
            suppliers, customers for Sheet and Foil, representatives and others
            to the extent necessary for the normal operation of its business.
            Novelis shall take reasonable precautions, consistent with past
            practices to preserve the value of the Information. Novelis shall
            advise the appropriate officers, employees, contractors, suppliers,
            customers, representatives and others to whom such information is
            supplied of the confidentiality obligation hereunder, and shall
            ensure that, where appropriate, they have agreed to comply with the
            provisions of this Article 7.0.

                                       15
<PAGE>

      7.6   The obligations of confidentiality and non-disclosure with respect
            to specific Information received under this Agreement or otherwise
            shall expire ten years after the Effective Date of this Agreement.

      7.7   The parties recognize that a breach of this Article 7.0 may give
            rise to irreparable injury to Alcanint that cannot be adequately
            compensated by monetary damages. Accordingly, in the event of a
            breach or threatened breach, Alcanint may be entitled to preliminary
            and permanent injunctive relief to prevent or enjoin a violation of
            this Article 7.0 and the unauthorized use or disclosure of any
            confidential Information in addition to such other remedies as may
            be available for such breach or threatened breach, including the
            recovery of damages.

      7.8   No provision of this Agreement shall be construed to require
            Alcanint to furnish any information (i) acquired from others on
            terms prohibiting or restricting disclosure by Alcanint, or (ii) the
            furnishing of which is in contravention of any law, regulation, or
            executive order of any government. Each party shall use its
            commercially reasonable efforts to avoid conditions that prevent the
            exchange of information under this Agreement.

      7.9   Nothing in this Agreement shall preclude Novelis from using any
            information that is in the public domain at the time of its use of
            such information unless such information is in the public domain as
            a result of Novelis' breach of the confidentiality obligations under
            this Article 7.0.

8.0   TERM AND TERMINATION

      8.1   This Agreement shall be effective until and shall terminate on the
            *** anniversary of the Effective Date except for the
            restrictions in respect of Transferred Technology as reflected in
            Section 5.2 which shall be effective until and shall terminate on
            the *** anniversary of the Effective Date. Upon termination
            pursuant to this Section 8.1, each of the licenses granted hereunder
            shall be deemed a fully-paid, unrestricted, unconditional, perpetual
            license, with the right to grant unrestricted sublicenses subject
            only to any patents held by Alcanint or an Alcan Group Company and
            to any obligations to pay any royalties due to any third party from
            which the Technology was originally acquired or licensed. For
            clarity, the parties intend that upon termination of this agreement
            pursuant to this Section 8.1, Novelis shall have all of the rights
            of a nonexclusive owner of the Licensed Technology, Unrestricted
            Technology and Transferred Technology and have an unrestricted,
            unconditional right to use and license such Technology without
            notice or accounting to Alcanint or any Alcan Group Company.

      8.2   Should there be a material default by Novelis in the performance of
            any of its obligations under this Agreement or under the Separation
            Agreement and such default is not cured within 30 days following
            written notification of such default

      *** Certain information on this page has been omitted and filed separately
          with the Securities and Exchange Commission. Confidential treatment
          has been requested with respect to the omitted portions.

                                       16
<PAGE>

            from Alcanint, this Agreement shall terminate on the date specified
            on such notice which shall not be less than 30 days following the
            date of such notice, unless Novelis cures such default before such
            specified termination date. This shall be referred to as early
            termination.

      8.3   This Agreement shall terminate immediately upon the occurrence of
            any of the following:

            (a)   the bankruptcy or insolvency of Novelis;

            (b)   the appointment of a receiver for Novelis' assets;

            (c)   the making by Novelis of a general assignment for the benefit
                  of creditors; or

            (d)   the institution by Novelis of proceedings for a reorganization
                  of Novelis under the Bankruptcy Act or similar legislation for
                  the relief of debtors or the institution of involuntary
                  proceedings by a party other than Novelis which are not
                  terminated in 30 days.

      8.4   All of the licenses of Licensed Technology shall terminate and this
            Agreement shall terminate (1) upon the occurrence of a Non Compete
            Breach (as defined in the Separation Agreement) and the giving of
            notice of such termination by Alcan to Novelis pursuant to Section
            14.03(b) of the Separation Agreement, or (2) upon the occurrence of
            a Change of Control Non Compete Breach (as defined in the Separation
            Agreement) and the giving of notice of such termination by Alcan to
            Novelis pursuant to Section 15.04 of the Separation Agreement. In
            the case of a termination of licenses of Licensed Technology granted
            to Novelis under this Agreement and termination of this Agreement
            pursuant to clause (1) or clause (2) hereof, such termination shall
            be effective immediately upon Alcan providing Novelis notice
            pursuant to Section 14.03(b) or Section 14.04(e) of the Separation
            Agreement, as the case may be and Novelis shall cease all use of the
            Licensed Technology that is the subject of licenses terminated
            pursuant to this section (including any license granted by virtue of
            Section 3.3). This section shall not preclude Novelis from using any
            information that is in the public domain at the time of its use of
            such information unless such information is in the public domain as
            a result of Novelis' breach of the confidentiality obligations under
            Article 7.0.

      8.5   This Agreement shall be terminated upon written notice from Alcanint
            in the event that (i) the Secondary Intellectual Property Agreement
            is at any time no longer in full force and effect (other than by
            virtue of a termination caused by the actions or inaction of
            Alcanint) or (ii) Novelis or any Novelis Subsidiary or any of their
            respective Affiliates asserts that the Secondary Intellectual
            Property Agreement is invalid, unenforceable or no longer in full
            force and

                                       17
<PAGE>

            effect and does not withdraw such assertion within five business
            days following a request to do so from Alcanint.

      8.6   Early termination pursuant to this Article 8.0 shall not prejudice
            Alcanint's rights to recover any amounts due at the time of such
            termination nor shall it prejudice any other remedy or cause of
            action or claim of Alcanint accrued or to accrue against Novelis on
            account of any such default by Novelis.

      8.7   This Agreement may be terminated at the option of Novelis, upon
            receipt of written notice to Alcanint, at any time provided all
            payments owed hereunder have been remitted to Alcanint.

      8.8   Upon early termination of this Agreement pursuant to this Article
            8.0, all licenses of any Licensed Technology shall terminate and
            Novelis shall cease all use of the Licensed Technology. This section
            shall not preclude Novelis from using any information that is in the
            public domain at the time of its use of such information unless such
            information is in the public domain as a result of Novelis' breach
            of the confidentiality obligations under Article 7.0.

      8.9   Notwithstanding the foregoing, Novelis may, after the date this
            Agreement is terminated pursuant to this Article 8.0 sell any
            product made before such termination, as if such product were sold
            prior to termination.

9.0   SURVIVAL OF OBLIGATIONS

      Except as otherwise provided in this agreement and unless otherwise agreed
      in writing by the parties, the rights and obligations of the parties under
      Articles 7.0, 10.0, 11.0, 12.0, 15.0, 16.0, 17.0, 18.0, 19.0, 21.0 and
      22.0 shall survive the termination of this Agreement.

10.0  REPRESENTATIONS; COVENANT

      Each party hereto represents that it has full power and authority to enter
      into this Agreement and to perform all obligations hereunder. Novelis
      further represents that it has fully power and authority to act as agent
      for each member of Novelis Group for all purposes under this Agreement.
      Novelis covenants that it will cause each member of Novelis Group to act
      strictly in accordance with the provisions of this Agreement.

11.0  DISCLAIMER

      11.1  Novelis acknowledges and agrees that the foregoing assignments and
            licenses are made on an "as is" quitclaim basis and that neither
            Alcanint nor any Alcan Group Company is providing or is responsible
            to provide any representation or warranty of any nature or kind
            (whether express, implied, statutory, contractual or other in nature
            and whether relating to title enforceability, merchantability,
            fitness for purpose, non-infringement, absence of rights of third
            parties or

                                       18
<PAGE>

            other) in respect of the Transferred Technology or, Licensed
            Technology or any use to be made thereof or any product to be
            produced therewith. Neither Alcanint nor any Alcan Group Company
            shall be liable to Novelis, or any other person, for any damage,
            injury or loss, including loss of use arising from any activities or
            obligations under this Agreement; or for any direct or indirect,
            incidental, consequential special or punitive damages.

      11.2  Nothing in this Agreement shall be construed as a warranty or
            representation that any product made, used, sold or otherwise
            disposed with the benefit of any rights or license granted pursuant
            to this Agreement is or will be free from infringement of patents of
            third parties.

      11.3  Neither Alcan nor any other Alcan Group Company nor any of their
            current Affiliates shall have any infringement action or claim
            against Novelis or any or its current Affiliates in respect of
            Designated Patents, Licensed Patents or Technology to the extent of
            any use of same prior to the Effective Date. None of Novelis, any
            Novelis Subsidiary nor any of their Affiliates shall have any
            infringement action against any Alcan Group Company in respect of
            any past, use of Technology. Each party, on behalf of itself and its
            Subsidiaries and Affiliates, hereby releases the other party and it
            Affiliates and Subsidiaries, from, and agrees not to sue concerning,
            any and all claims for infringement in respect of any use of
            Technology prior to the Effective Date, whether based on contract,
            tort, statutory or other legal or equitable theory of recovery,
            which such party (or its Subsidiaries or Affiliates) has asserted or
            could have asserted against the other party (or its Subsidiaries or
            Affiliates). Promptly following the Effective Date, the relevant
            Alcan Group Company (or Affiliate) and Novelis (or Affiliate) shall
            promptly execute and deliver stipulations of dismissal with
            prejudice of any claims filed in respect of any such alleged
            infringement, in forms suitable for immediate filing in the relevant
            court.

      11.4  Without limiting Section 11.1 hereof, in no event shall either party
            or any of their respective Affiliates be liable to the other party
            or its Affiliates for any special, consequential, indirect,
            incidental or punitive damages or lost profits, however caused and
            on any theory of liability (including negligence) arising in any way
            out of this Agreement, whether or not such party has been advised of
            the possibility of such damages.

12.0  TRADEMARK, TRADE NAME AND LOGO

      No right is conveyed under this Agreement for the use, either directly,
      indirectly, by implication or otherwise, of any trademark, trade name or
      logo owned by Alcanint or any Alcan Group Company. The parties will enter
      into a separate trademark license agreement if appropriate.

                                       19
<PAGE>

13.0  NON-WAIVER

      The failure of any party to insist in any one or more instances upon the
      strict performance of any one or more of the obligations of this Agreement
      or to exercise any election herein contained, shall not be construed as a
      waiver for the future of the performance of such one or more obligations
      of this Agreement or of the right to exercise such election. No waiver of
      any breach or default of this Agreement shall be held to be a waiver for
      any subsequent breach.

14.0  NO PARTNERSHIP, JOINT VENTURE

      The parties to this Agreement agree and acknowledge that the Agreement
      does not create a partnership, joint venture or any other relationship
      between Alcanint and Novelis save the relationship specifically set out
      herein before and solely for the limited purposes herein.

15.0  FURTHER ASSURANCES, CONSENTS, ETC.

      The parties to this Agreement shall co-operate together using their
      respective commercially reasonable best efforts to take such further
      steps, including the execution and delivery of documentation and
      applications which are required for legal or regulatory purposes or to
      obtain the consents or approvals of third parties or necessary or
      advisable registrations. All fees and expenses related to registrations
      which are advisable or necessary shall be at the expense of the future
      owner of such registrations and all registrations will be the
      responsibility of such owner. Nothing contained in this Agreement shall be
      interpreted to oblige any party to do anything more than apply its
      commercially reasonable best efforts (without material expense to it) to
      obtain any consent, approval or registration which may be required to give
      full effect to the terms and conditions hereof. Similarly, no party shall
      be obliged to convey any rights or do any other thing which would cause it
      to be in breach of any legal or contractual obligation.

16.0  NOTICES

      Any notice, consent or other instrument required or permitted to be given
      by one party to the other party hereunder shall be in writing and shall be
      delivered or sent by first class mail or telefax and shall be deemed
      received five days following prepaid mailing or the next business day when
      telefaxed to the other party with receipt confirmation at the addresses
      set forth below;

                                       20
<PAGE>

       To Alcanint:         Alcan International Limited
                            1188 Sherbrooke Street West
                            Montreal, Quebec, Canada H3A 3G2

                            Fax: (514) 848-8555
                            Attention: Company Secretary

                            In all cases with copy (which shall not constitute
                            notice) to:
                            Alcan Inc.
                            1188 Sherbrooke Street West
                            Montreal, Quebec, Canada H3A 3G2

                            Fax: (514) 848-8555
                            Attention: Company Secretary

      To Novelis:           Novelis Inc.
                            Suite 3800
                            Royal Bank Plaza, South Tower
                            P. O. Box 84
                            200 Bay Street
                            Toronto, Ontario, Canada  M5J 2Z4

                            Fax: (416) 216-3930
                            Attention: President

      Either party may change the notice address by giving written notice to the
      other party. If sent by telefax, a confirming copy of such shall be sent
      by regular mail to the addressee.

17.0  ASSIGNMENT

      17.1  This Agreement shall not be assignable, in whole or in part,
            directly or indirectly, by any party hereto without the prior
            written consent of the others, and any attempt to assign any rights
            or obligations under this Agreement without such consent shall be
            null and void and deemed to be in breach hereof.

      17.2  Notwithstanding the preceding Section 17.1, this Agreement may be
            assigned (i) by Alcanint to any Alcan Group Company, by Novelis to
            any Novelis Subsidiary and (ii) by either party in whole in
            connection with a merger or consolidation or the sale of all or
            substantially all of the assets of such Party, or (iii) by Novelis
            in part in connection with a sale or other divestiture of a Novelis
            Subsidiary, plant, or business unit whose field of activity is
            principally related to the portion of Novelis' business that makes
            actual use of the Technology licensed under this Agreement;
            provided, however, that such assignee must expressly agree in
            writing to be bound by the terms and conditions of this Agreement.

                                       21
<PAGE>

      17.3  Nothing in this Article 17.0 shall operate to entitle any transfer,
            assignment or license to any entity which has any activities
            directly or through Affiliates of a type which would be contrary to
            Section 8.4. Any such transfer assignment, or license (actual or
            attempted) shall in all aspects be void ab initio and any attempted
            assignment in violation thereof shall be deemed to constitute a
            material default within the meaning of Section 8.2 hereunder.

18.0  INDEMNIFICATION

      18.1  Novelis shall indemnify, defend and hold harmless Alcanint and all
            Alcan Group Companies and their respective directors and officers
            (the "ALCANINT INDEMNITEES") from and against any and all losses
            incurred or suffered by any of the Alcanint Indemnitees arising out
            of the use of any Transferred Technology or Licensed Technology by
            Novelis or any of its Affiliates or customers.

      18.2  If any Alcanint Indemnitee determines that it is or may be entitled
            to indemnification by any party (the "INDEMNIFYING PARTY"), under
            this Article 18.0, (other than in connection with an action subject
            to Section 18.3), the Indemnified Party shall deliver to the
            Indemnifying Party a written notice describing to the extent
            reasonably practicable, the basis for its claim for indemnification
            and the amount for which the Indemnified Party reasonably believes
            it is entitled to be indemnified. If the Indemnifying Party has not
            responded within 30 days after receipt of such notice, the
            Indemnified Party shall deliver a second notice to the Indemnifying
            Party within ten days of the expiration of the original 30 day
            period. Within 30 days after receipt of any second notice, the
            Indemnifying Party shall pay the Indemnified Party such amount in
            cash or other immediately available funds unless the Indemnifying
            Party objects to the claim for indemnification or the amount
            thereof.

      18.3  Promptly following the earlier of (i) receipt of notice of the
            commencement of an action by a third party against or otherwise
            involving any indemnified party, or (ii) receipt of information from
            a third party alleging the existence of a claim against an
            Indemnified Party, in either case, with respect to which
            indemnification may be sought pursuant to this Agreement, (a "THIRD
            PARTY CLAIM"), the Indemnified Party shall give the Indemnifying
            Party written notice thereof. The failure of the Indemnified Party
            to give notice as provided in this Article 18.0 shall not relieve
            the Indemnifying Party of its obligations under this Agreement,
            except to the extent that the Indemnifying Party is prejudiced by
            such failure to give notice. Within 30 days after receipt of such
            notice, the Indemnifying Party may (i) by giving written notice
            thereof to the Indemnified Party, acknowledge liability for such
            indemnification claim and at is option elect to assume the defence
            of such Third Party Claim at its sole cost and expense or (ii)
            object to the claim for indemnification set forth in the notice
            delivered by the Indemnified Party pursuant to the first sentence of
            this Section 18.3;

                                       22
<PAGE>

            provided that if the Indemnifying Party does not within such 30 day
            period give the Indemnified Party written notice objecting to such
            indemnification claim and setting forth the grounds therefor, the
            Indemnified Party shall give the Indemnifying Party an additional
            notice of its claim for indemnification and if the Indemnifying
            Party does not give the Indemnified Party written notice objecting
            to such claim within ten days after receipt of such notice the
            Indemnifying Party shall be deemed to have acknowledged its
            liability for such indemnification claim. If the Indemnifying Party
            has elected to assume the defence of a Third Party Claim, (x) the
            defence shall be conducted by counsel retained by the Indemnifying
            Party and reasonably satisfactory to the Indemnified Party, provided
            that the Indemnified Party shall have the right to participate in
            such proceedings and to be represented by counsel of its own
            choosing at the Indemnified Party's sole cost and expense; and (y)
            the Indemnifying Party may settle or compromise the third Party
            claim without the prior written consent of the Indemnified Party so
            long as such settlement includes and unconditional release of the
            Indemnified Party from all claims that are the subject of such Third
            Party Claim provided the Indemnifying Party may not agree to any
            such settlement pursuant to which any remedy or relief, other than
            money damages for which the Indemnifying Party shall be responsible
            hereunder, shall be applied to or against the Indemnified Party,
            without the prior written consent of the Indemnified Party, which
            consent shall not be unreasonably withheld. If the Indemnifying
            Party does not assume the defence of a Third Party Claim for which
            it has acknowledged liability for indemnification hereunder, the
            Indemnified Party may require the Indemnifying Party to reimburse it
            on a current basis for its reasonable expenses of defending against
            such Third Party Claim and the Indemnifying party shall be bound by
            the result obtained with respect thereto by the Indemnified Party;
            provided that the Indemnifying Party shall not be liable for any
            settlement effected without its consent, which consent shall not be
            unreasonably withheld. The Indemnifying Party shall pay to the
            Indemnified Party in cash the amount, if any, for which the
            Indemnified Party is entitled to be indemnified hereunder within 15
            days after such Third Party Claim has been finally determined, or in
            the case of an indemnity claim as to which the Indemnifying Party
            has not acknowledged liability, within 15 days after such
            Indemnifying Party's objection to liability hereunder has been
            finally determined.

      18.4  If for any reason the indemnification provided for in Section 18.1
            is unavailable to an Indemnified Party, or insufficient to hold it
            harmless, then the Indemnifying Party shall contribute to the amount
            paid or payable to such Indemnified Party as a result of such losses
            in such proportion as is appropriate to reflect all relevant
            equitable considerations.

      18.5  The remedies provided for in this Article 18.0 are not exclusive and
            shall not limit any rights or remedies which may otherwise be
            available to any Indemnified Party at law or in equity.

                                       23
<PAGE>

19.0  ENTIRE AGREEMENT, AMENDMENTS

      19.1  This Agreement constitutes the entire agreement and understanding
            between the parties with respect to the subject matter hereof and
            supersedes all prior agreements, understandings, negotiations and
            discussions whether oral or written of the parties, and there are no
            representations, warranties or conditions expressed or implied or
            otherwise between the parties in connection with the subject matter
            hereof, except as specifically set forth herein. No amendment to the
            terms and conditions hereof or waiver in respect thereto shall be
            binding unless it is in writing and signed by duly authorized
            representatives of both parties.

      19.2  Notwithstanding the foregoing, the rights and interests transferred,
            assigned or granted to Novelis or Novelis Subsidiaries or otherwise
            to be made available to them pursuant to the terms of this
            Agreement, shall in all respects be subject to the provisions of the
            Separation Agreement and nothing in this Agreement shall entitle
            Novelis or Novelis Subsidiaries to have any rights or pursue any
            activity which would otherwise be restricted by the Separation
            Agreement. The Separation Agreement shall not in defining the
            assets, businesses, rights and obligations to form part of Novelis,
            be interpreted so as to grant, convey or confirm, directly or
            indirectly, any rights on the part of Novelis in respect of
            Technology which would be greater than those established herein.

20.0  DISPUTE RESOLUTION

      The Master Agreement with Respect to Dispute Resolution, effective on the
      Effective Date, among Alcanint, Novelis and other parties thereto shall
      govern all disputes, controversies or claims (whether arising in contract,
      delict, tort or otherwise) between the Parties that may arise out of, or
      relate to, or arise under or in connection with, this Agreement or the
      transactions contemplated hereby (including all actions taken in
      furtherance of this Agreement) or the commercial or economic relationship
      of the Parties relating hereto or thereto.

21.0  MISCELLANEOUS

      21.1  The division of this Agreement into sections, subsections and other
            subdivisions and the insertion of headings are for convenience of
            reference only and shall not affect or be utilized in the
            construction or interpretation of this Agreement.

      21.2  The parties hereto have requested that this Agreement and all other
            documents, notices or written communications relating thereto, be in
            the English language.

                                       24
<PAGE>

      21.3  The parties may amend this Agreement only by a written agreement
            signed by each party to be bound by the amendment and that
            identifies itself as an amendment to this Agreement.

      21.4  Except as expressly stated to the contrary herein, the provisions of
            this Agreement are solely for the benefit of the parties and are not
            intended to confer upon any person except the parties any rights or
            remedies hereunder, and there are no third party beneficiaries of
            this Agreement, and this Agreement shall not provide any third
            person with any remedy, claim, liability, reimbursement, claim of
            action or other right in addition to those existing without
            reference to this Agreement.

22.0  GOVERNING LAW

      Recognizing the numerous jurisdictions associated with this Agreement and
      the activities contemplated by it, the parties agree that this Agreement
      shall be governed, construed and interpreted according to the laws of the
      Province of Quebec, Canada without the application of the provisions
      relating to the conflict of laws. Any provision in this Agreement
      prohibited by law or by court decree shall be ineffective to the extent of
      such prohibition without in any way invalidating or affecting the
      remaining provisions of this Agreement, and this Agreement shall be
      construed as if such prohibited provision had never been contained herein.
      Alcanint and Novelis hereby agree, however, to negotiate an equitable
      amendment of this Agreement if a material provision is adversely affected.

IN WITNESS WHEREOF duly authorised representatives of the parties hereto have
signed duplicate copies of this Agreement.

ALCAN INTERNATIONAL LIMITED                          NOVELIS INC.

Per: ......................                          Per: ......................

Per: ......................                          Per: ......................

                                  INTERVENTION

Alcan Inc. has intervened in this Agreement to acknowledge its terms and agree
to be bound by and benefit from same.

ALCAN INC.

Per: .......................

Per: .......................

                                       25

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]